Related Experiment Video
Updated: May 4, 2026

Monitoring GPCR-β-arrestin1/2 Interactions in Real Time Living Systems to Accelerate Drug Discovery
Published on: June 28, 2019
Monitoring G protein-coupled receptor activation using an adenovirus-based β-arrestin bimolecular fluorescence
Yong Bhum Song1, Chul O Park1, Jae-Yeon Jeong2
1Department of Biological Sciences and Research Center for Functional Cellulomics, Seoul National University, Seoul 151-747, Republic of Korea.
Abstract:
G protein-coupled receptors (GPCRs) are the largest family of cell-surface receptors and are involved in a variety of pathological conditions including cancer and cardiovascular, metabolic, neurological, and autoimmune diseases. GPCRs are being intensively investigated as targets for therapeutic intervention, and the β-arrestin recruitment assay has become a popular tool for analyzing GPCR activation. Here, we report a high-throughput method for cloning GPCR cDNAs into adenoviral bimolecular fluorescence complementation (BiFC) vectors and performing the β-arrestin BiFC assay in cells transduced with recombinant adenoviruses. An analysis of the activation of somatostatin receptor 2 (SSTR2) with the adenovirus-based β-arrestin BiFC assay showed that the assay is suitable for quantifying SSTR2 activation in response to specific agonists or antagonists. Furthermore, the adenovirus-based β-arrestin BiFC assay was able to detect the activation of a broad range of GPCRs. Collectively, our data indicate that the adenovirus-based β-arrestin BiFC assay can serve as a simple and universal platform for studying GPCR activation and thus will be useful for high-throughput screening of drugs that target GPCRs.
Insights
This study introduces a new, high-throughput adenovirus-based assay for studying G protein-coupled receptors (GPCRs). This method simplifies the analysis of GPCR activation and drug screening for various diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- G protein-coupled receptors (GPCRs) are crucial cell-surface receptors implicated in numerous diseases.
- GPCRs are significant therapeutic targets, necessitating efficient methods for studying their activation.
- The beta-arrestin recruitment assay is a key tool for analyzing GPCR activation.
Purpose of the Study:
- To develop a high-throughput method for cloning GPCR cDNAs into adenoviral vectors.
- To establish and validate an adenovirus-based beta-arrestin bimolecular fluorescence complementation (BiFC) assay for GPCR activation.
- To demonstrate the utility of this assay for drug screening targeting GPCRs.
Main Methods:
- Cloning of GPCR cDNAs into adenoviral BiFC vectors.
- Transduction of cells with recombinant adenoviruses.
- Performing beta-arrestin BiFC assays to quantify GPCR activation.
Main Results:
- The adenovirus-based beta-arrestin BiFC assay successfully quantified somatostatin receptor 2 (SSTR2) activation by agonists and antagonists.
- The assay demonstrated broad applicability, detecting activation across a wide range of GPCRs.
- The method proved suitable for high-throughput analysis.
Conclusions:
- The adenovirus-based beta-arrestin BiFC assay provides a simple and universal platform for studying GPCR activation.
- This assay is valuable for high-throughput screening of drugs targeting GPCRs.
- The developed method facilitates research into GPCRs and associated diseases.
More Related Videos
Related Concept Videos
G-protein Coupled Receptors
Activation and Inactivation of G Proteins
GPCRs Regulate Adenylyl Cylase Activity

